ArticleProbiotics and antimicrobial proteins2026
Identification and Functional Characterization of an Ancestral Hepcidin-Like Antimicrobial Peptide in the Lamprey (Lethenteron camtschaticum).
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Hepcidin, also known as LEAP-1 (liver-expressed antimicrobial peptide), is a cysteine-rich, cationic antimicrobial peptide found in vertebrates that plays a key role in iron transport and immune response. Although hepcidin has been characterized in various vertebrates, including fish and mammals, its evolutionary origin remains unclear. In this study, the ancestral hepcidin gene (named Lc-HAMP) was cloned and characterized from the liver of the primitive jawless vertebrate Lethenteron camtschaticum (lamprey). The gene encodes a 25-amino-acids signal peptide and a mature 23-amino- acids peptide. Despite relatively low sequence similarity with other species, the mature Lc-HAMP peptide retains eight conserved cysteine residues that form a core structure of four disulfide bonds. Lc-HAMP expression is significantly upregulated upon multiple immune challenges, and the mature peptide exhibits dose-dependent in vitro antimicrobial activity against a wide range of bacteria, including Staphylococcus aureus, Staphylococcus epidermidis, and Aeromonas, but shows no activity against Escherichia coli and Pseudomonas aeruginosa. Lc-HAMP induces bacterial membrane damage and triggers reactive oxygen species (ROS) bursts in bacteria. Transcriptomic and metabolomic analyses indicate that overexpression of Lc-HAMP in HEK293T cells affects endoplasmic reticulum stress and glutathione metabolism, similarly to observations in higher vertebrates. These findings shed light on the evolutionary origin of hepcidin, a key antimicrobial peptide, and suggest potential strategies for preventing and controlling immunosuppression in lower vertebrates such as fish.
Indexed as
Identifiers
40650834What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.